Purpose Of Review: Patterns of sexualized drug use, including stimulants (e.g., methamphetamine) and chemsex drugs, are key drivers of HIV incidence among sexual minority men (SMM). Although pre-exposure prophylaxis (PrEP) mitigates HIV risk, there is no consensus regarding the associations of substance use with the PrEP care continuum.
Recent Findings: SMM who use substances are as likely or more likely to use PrEP. Although SMM who use stimulants experience greater difficulties with daily oral PrEP adherence, some evidence shows that SMM who use stimulants or chemsex drugs may achieve better adherence in the context of recent condomless anal sex. Finally, SMM who use substances may experience greater difficulties with PrEP persistence (including retention in PrEP care). SMM who use stimulants and other substances would benefit from more comprehensive efforts to support PrEP re-uptake, adherence, and persistence, including delivering behavioral interventions, considering event-based dosing, and providing injectable PrEP.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279195 | PMC |
| http://dx.doi.org/10.1007/s11904-022-00608-y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Substance use disorder and severe maternal morbidity: is there a differential impact?
Am J Obstet Gynecol MFM
November 2024
Department of Obstetrics, Gynecology, and Women's Health, Division of Maternal Fetal Medicine, Saint Louis University/SSM Health, St. Louis, MO (Keller and Chavan). Electronic address:
Background: Substance use disorder (SUD) is a disease characterized by behavior patterns of substance use leading to dysfunction in cognition, mood, and quality of life. The prevalence of perinatal SUD in the United States continues to rise and has adverse effects on the maternal-infant dyad. Mirroring the rise in SUD is an increasing prevalence of severe maternal morbidity (SMM).
View Article and Find Full Text PDFMapping a psychosocial syndemic among methamphetamine-using sexual minority men living with HIV.
Drug Alcohol Rev
November 2024
Robert Stempel College of Public Health & Social Work, Florida International University, Miami, Florida, USA.
Article Synopsis
- The study examines the complex relationship between psychosocial factors and methamphetamine use among sexual minority men living with HIV, using syndemic theory to understand these dynamics.
- Researchers utilized both quantitative surveys and qualitative interviews to gather data on how elements like post-traumatic stress disorder and depression contribute to substance use.
- Findings indicate that these psychosocial issues not only promote methamphetamine use as a coping mechanism but also hinder recovery, highlighting the need for interventions that address these interconnected challenges.
Supporting treatment adherence for resilience and thriving (START): protocol for a mHealth randomized controlled trial.
BMC Public Health
August 2024
Department of Disease Prevention and Health Promotion, Robert Stempel College of Public Health & Social Work, Florida International University, 11200 S.W. 8th Street, AHC5, #407, Miami, Fl, 33199, USA.
Background: Although behavioral interventions show some promise for reducing stimulant use and achieving durable viral suppression in sexual minority men (SMM) with HIV, scalable mHealth applications are needed to optimize their reach and cost-effectiveness.
Methods: Supporting Treatment Adherence for Resilience and Thriving (START) is a randomized controlled trial (RCT) testing the efficacy and cost-effectiveness of a mHealth application that integrates evidence-based positive affect regulation skills with self-monitoring of adherence and mood. The primary outcome is detectable HIV viral load (i.
Challenges and Opportunities with at-Home Blood Collection for HIV-1 Viral Load Monitoring among Sexual Minoritized Men who use Stimulants.
AIDS Behav
November 2024
Department of Medicine, STAR Program, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
Sexually minoritized men (SMM) with HIV who use stimulants experience difficulties achieving and maintaining an undetectable viral load (VL). Home-based VL monitoring could augment HIV care by supporting interim, early identification of detectable VL. We describe implementation challenges associated with a home-collection device for laboratory-based VL testing among SMM with HIV who use stimulants.
View Article and Find Full Text PDFTrends and adverse pregnancy and birth outcomes associated with stimulant-related disorder diagnosis.
Addiction
November 2024
Department of Pediatrics, University of California, San Diego, La Jolla, CA, USA.
Article Synopsis
- The study investigates stimulant-related disorders (SRD) during pregnancy and their impact on maternal and infant health outcomes in California from 2012 to 2020, highlighting a significant increase in SRD diagnoses.
- Findings indicate that SRD diagnosis is linked to higher risks of severe maternal morbidity, gestational hypertension, very preterm births, and neonatal intensive care unit admissions.
- Researchers used a large cohort of over 3.7 million singleton births drawn from the Study of Outcomes in Mothers and Infants (SOMI) and utilized statistical methods to assess the risks while accounting for various maternal health factors.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!